Suppr超能文献

基因检测相关风险:是健康保险歧视还是一切照旧?

Risks associated with genetic testing: health insurance discrimination or simply business as usual?

作者信息

Steinberg K K

出版信息

J Am Med Womens Assoc (1972). 2000 Summer;55(4):241-2.

Abstract

Doctors can test patients for mutations that put them at high risk for hereditary forms of such diseases as breast and ovarian cancer. Even though the opportunities for disease prevention using genetic testing will increase with time, the risks of testing, which include insurance loss and employment discrimination, currently make testing problematic. Some have proposed making use of genetic information in health insurance underwriting illegal. But in the current system of risk-based underwriting, it is hard to imagine that insurance companies will willingly forego access to a growing body of information on risk. If the American public chooses to limit the use of genetic information, a reassessment of current laws or methods of paying for health care will be needed.

摘要

医生可以检测患者是否携带某些突变,这些突变会使他们患乳腺癌和卵巢癌等遗传性疾病的风险升高。尽管随着时间的推移,利用基因检测进行疾病预防的机会将会增加,但目前检测的风险,包括失去保险和就业歧视,使得检测存在问题。一些人提议将在健康保险承保中使用基因信息定为非法行为。但在当前基于风险的承保体系下,很难想象保险公司会心甘情愿地放弃获取越来越多的风险信息。如果美国公众选择限制基因信息的使用,那么就需要重新评估现行法律或医疗保健支付方式。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验